Pralsetinib

From WikiMD.org
Jump to navigation Jump to search
Pralsetinib
TermPralsetinib
Short definitionPralsetinib - (pronounced) (pral-SEH-tih feather) drug used to treat adults with non-small cell lung cancer that carries a RET fusion gene and adults and children 12 years and older with certain types of thyroid cancer, including medullary thyroid cancer, that carry a RET fusion gene or a mutation (change) in RET -Gene. It is used in patients whose cancer is advanced or has spread to other parts of the body. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Pralsetinib - (pronounced) (pral-SEH-tih feather) drug used to treat adults with non-small cell lung cancer that carries a RET fusion gene and adults and children 12 years and older with certain types of thyroid cancer, including medullary thyroid cancer, that carry a RET fusion gene or a mutation (change) in RET -Gene. It is used in patients whose cancer is advanced or has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Pralsetinib blocks certain proteins made by the RET fusion gene or the mutated RET gene, which can help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called Gavreto

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski